Boning Zhang

Boning Z. is a Senior Scientist at TScan Therapeutics, focusing on the development of potency assays through Design of Experiments and risk assessment methodologies. With previous experience at Intellia Therapeutics as a Senior Scientist, Boning Z. optimized in vitro assays for an allogenic CAR T cell platform and collaborated with various teams on research initiatives, including patent filings for CRISPR editing targets. Earlier roles included a postdoctoral researcher position at Dana-Farber Cancer Institute and a research assistantship at Purdue University, where research centered on targeted delivery systems for CAR T cell therapies. Boning Z. holds a Ph.D. in Biomedicine from Purdue University and a Bachelor's degree in General Medicine from Peking University.